Feedback / Questions
OR502 - OncoResponse
https://www.prnewswire.com/news-releases/oncoresponse-announces-initiation-of-phase-12-clinical-trial-of-or502-anti-lilrb2-antibody-in-subjects-with-advanced-cancer-302000171.html
Nov 29, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next